Key Takeaways
- Phentermine and Zepbound® work through completely different mechanisms. Phentermine is a stimulant that suppresses appetite by increasing norepinephrine in the brain, while Zepbound® mimics two gut hormones that regulate blood sugar, appetite, and fat storage.
- Zepbound® shows significantly stronger weight loss results in clinical trials, with participants losing up to 20.9% of their body weight over 72 weeks compared to around 9% over 12 weeks with phentermine.
- Phentermine is FDA-approved for short-term use only and can raise heart rate and blood pressure, making it unsuitable for people with cardiovascular conditions. Zepbound® is approved for long-term use but carries its own contraindications around thyroid and endocrine history.
- Cost is a real differentiator. Phentermine can cost as little as $10 for a month's supply, while Zepbound® ranges from $299 to $699 without insurance coverage.
Phentermine and Zepbound® are both FDA-approved prescription medications for weight management, used alongside a structured diet and exercise program. Past that, they have little in common. Phentermine is a stimulant, first approved back in 1959. Zepbound®, on the other hand, is a GLP-1 medication, approved more recently in 2023.
So, which one might be the right choice for you? Read on as we compare phentermine versus Zepbound® so you can make an informed choice.
How do phentermine and Zepbound® work? Key differences explained
Navigating weight loss medications can be confusing, but understanding how treatments like phentermine and Zepbound® work can help you decide.
How phentermine works
Phentermine is a generic drug that belongs to a class of medications called sympathomimetic amines. These medicines mirror the effects of your body’s natural alert and survival system (sympathetic nervous system). They do this by stimulating the release or activity of certain chemical messengers (neurotransmitters) in your brain.
The main neurotransmitter that phentermine prompts is called norepinephrine. It’s primarily responsible for keeping you alert, focused, and energized. High norepinephrine levels signal your brain’s appetite center (hypothalamus) to lower hunger. While we know phentermine primarily works by increasing norepinephrine levels, scientists still don’t understand the full extent of how the drug works.
How tirzepatide (Zepbound®) works
We have a broader understanding of another weight loss medication, tirzepatide (the active ingredient in the brand Zepbound®). Tirzepatide mimics two hormones your body naturally produces, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP).
Insulin allows sugar from your food to enter your cells to be used for energy. GLP-1 and GIP are both incretin hormones, meaning they prompt your pancreas to release insulin in response to rising blood sugar levels after a meal. This prevents your blood sugar levels from spiking dangerously high.
Beyond managing insulin, GLP-1 and GIP have other jobs:
- GLP-1 acts on both your hypothalamus and your stomach to suppress appetite and slow down how fast your stomach empties after a meal. This makes you feel fuller faster and for longer.
- GIP increases the effectiveness of GLP-1. GIP also works directly on your body’s fat (adipose) tissue, helping under-the-skin (subcutaneous) fat expand to handle incoming nutrients. In doing this, GIP prevents excess fat from accumulating around your organs as harmful visceral fat.
Phentermine vs. tirzepatide: At a glance
Here’s a quick side-by-side comparison of both medications:
Which one is more effective for weight loss, phentermine or Zepbound®?
Currently, there aren’t any studies directly comparing phentermine and tirzepatide. However, Zepbound® overall has better weight loss results in individual trials.
Tirzepatide’s efficacy
The 2022 SURMOUNT-1 trial tracked participants with a body mass index (BMI) of 30 or greater, or a BMI of 27 or greater with at least one weight-related condition like high blood pressure. Researchers prescribed each a weekly injection of tirzepatide (5 mg, 10 mg, or 15 mg) or a placebo. Over 72 weeks, participants reached these weight loss thresholds:
These outcomes demonstrate tirzepatide’s effectiveness is a key contributor to Zepbound’s®
FDA approval for chronic weight management.
Phentermine’s efficacy
Phentermine’s body of research evidence mainly includes older, smaller, and shorter studies. One, published in Yonsei Medical Journal in 2006, split participants with a BMI of 25 or greater into two groups: a 37.5 mg dose of phentermine or placebo. Over 12 weeks, participants reached these weight loss thresholds:
Beyond weight loss: Zepbound® for obstructive sleep apnea
The FDA approves phentermine and tirzepatide for weight management. However, in 2024, the FDA expanded Zepbound’s® approval to cover moderate-to-severe obstructive sleep apnea (OSA) in adults with a BMI of 30 or higher. OSA is a disorder where your airway repeatedly closes during sleep, which can lead to daytime fatigue, high blood pressure, and heart problems.
One SURMOUNT-OSA trial tested tirzepatide against placebo among participants using a breathing device, called positive airway pressure (PAP) therapy. Another other made the same comparison among non-PAP users. Here’s what researchers found:











